Compare PACB & BLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PACB | BLW |
|---|---|---|
| Founded | 2000 | N/A |
| Country | United States | United States |
| Employees | 575 | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Other Consumer Services |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 459.0M | 532.2M |
| IPO Year | 2010 | 2003 |
| Metric | PACB | BLW |
|---|---|---|
| Price | $1.37 | $13.43 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $2.20 | N/A |
| AVG Volume (30 Days) | ★ 5.9M | 81.1K |
| Earning Date | 05-04-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $93,468,000.00 | N/A |
| Revenue This Year | $11.22 | N/A |
| Revenue Next Year | $12.41 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3.04 | N/A |
| 52 Week Low | $0.85 | $12.48 |
| 52 Week High | $2.73 | $14.28 |
| Indicator | PACB | BLW |
|---|---|---|
| Relative Strength Index (RSI) | 33.19 | 26.67 |
| Support Level | $1.36 | N/A |
| Resistance Level | $1.73 | $14.21 |
| Average True Range (ATR) | 0.12 | 0.10 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 5.66 | 0.00 |
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.
Blackrock Ltd Duration Income Trust is a diversified investment fund with an investment objective to provide current income and capital appreciation. The Fund's portfolio normally has an average portfolio duration of less than five years. The Fund may invest directly in such securities or synthetically through the use of derivatives.